Disc Medicine (IRON) Amortizatization of Intangibles (2024 - 2026)
Disc Medicine (IRON) reported Amortizatization of Intangibles of $1.1 million for Q1 2026, down 57.7% year-over-year from $2.5 million in Q1 2025, and down 34.5% on a QoQ basis from $1.6 million in Q4 2025.
Disc Medicine (IRON) has 3 years of Amortizatization of Intangibles data on file, last reported at $1.1 million in Q1 2026.
- Quarterly Amortizatization of Intangibles fell 57.7% year-over-year to $1.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $7.1 million (down 9.83% YoY) and the FY2025 annual result came in at $8.5 million, up 60.61% from the prior year.
- Amortizatization of Intangibles fell to $1.1 million in Q1 2026 per IRON's latest filing, from $1.6 million in the prior quarter.
- Across five years, Amortizatization of Intangibles topped out at $2.6 million in Q2 2025 and bottomed at $596000.0 in Q2 2024.
- The 3-year median for Amortizatization of Intangibles is $2.0 million (2024), against an average of $1.9 million.
- The widest annual swing landed in 2025, when Amortizatization of Intangibles surged 339.77%; it then plunged 57.7% in 2026.
- Tracing IRON's Amortizatization of Intangibles over 3 years: stood at $2.2 million in 2024, then slipped by 26.22% to $1.6 million in 2025, then slumped by 34.5% to $1.1 million in 2026.
- Per Business Quant, the three latest IRON Amortizatization of Intangibles figures stand at $1.1 million (Q1 2026), $1.6 million (Q4 2025), and $1.7 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 13,267.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Disc Medicine | 2.76 Bn | 2.03 Bn | - | 1.07 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.07 Mn |
| Mar 31, 2026 | 1.07 Mn |
| Dec 31, 2025 | 1.63 Mn |
| Dec 31, 2025 | 1.63 Mn |
| Sep 30, 2025 | 1.74 Mn |
| Sep 30, 2025 | 1.74 Mn |
| Jun 30, 2025 | 2.62 Mn |
| Jun 30, 2025 | 2.62 Mn |
| Mar 31, 2025 | 2.53 Mn |
| Mar 31, 2025 | 2.53 Mn |
| Dec 31, 2024 | 2.21 Mn |
| Dec 31, 2024 | 2.21 Mn |
| Sep 30, 2024 | 2.50 Mn |
| Sep 30, 2024 | 2.50 Mn |
| Jun 30, 2024 | 596,000.00 |
| Jun 30, 2024 | 596,000.00 |